Jump to content
  • Sign Up
0
Scott Adams

Avaxia Biologics is Awarded Patent for its Proprietary Orally Active Antibody ... - Sacramento Bee

Rate this topic

Recommended Posts

Avaxia Biologics is Awarded Patent for its Proprietary Orally Active Antibody ...

Sacramento Bee

This patent, which expires on May 27, 2029, provides broad coverage for treating celiac disease using orally administered antibodies produced by the Company's proprietary platform technology. This newly issued patent includes claims covering the ...

and more »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×